| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action
DOI: 10.1016/j.eururo.2012.01.046
Abstract: Background: OnabotulinumtoxinA (Onabot/A) has been used to treat detrusor overactivity disorders. The treatment is based on several injections of toxin throughout the bladder wall. However, ...
|
Ana Coelho,
Francisco Cruz,
Célia D. Cruz,
António Avelino
|
Full-length article
(In Press Uncorrected Proof)
|
03 February 2012 |
|
Three-Tesla Magnetic Resonance–Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers
DOI: 10.1016/j.eururo.2012.01.047
Abstract: Background: Patients with elevated prostate-specific antigen (PSA) and one or more previous negative transrectal ultrasound (TRUS) biopsy sessions are subject to diagnostic uncertainty due t...
|
Caroline M.A. Hoeks,
Martijn G. Schouten,
Joyce G. Bomers,
Stefan Hoogendoorn,
Christina A. Hulsbergen-van de Kaa,
Thomas Hambrock,
Henk Vergunst,
Michiel Sedelaar,
Jurgen J. Fütterer,
Jelle O. Barentsz
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
03 February 2012 |
|
Glycine Transporter Type 2 (GlyT2) Inhibitor Ameliorates Bladder Overactivity and Nociceptive Behavior in Rats
DOI: 10.1016/j.eururo.2012.01.044
Abstract: Background: Glycine is a major inhibitory neurotransmitter in the spinal cord, the concentration of which is regulated by two types of glycine transporters (GlyTs): GlyT1 and GlyT2. We hypot...
|
Satoru Yoshikawa,
Tomohiko Oguchi,
Yasuhito Funahashi,
William C. de Groat,
Naoki Yoshimura
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
03 February 2012 |
|
Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
DOI: 10.1016/j.eururo.2012.01.045
Abstract: Background: Previous studies demonstrate that androgen-deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonists and orchiectomy for prostate cancer (PCa) is associated w...
|
Jim C. Hu,
Stephen B. Williams,
A. James O’Malley,
Matthew R. Smith,
Paul L. Nguyen,
Nancy L. Keating
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
03 February 2012 |
|
Reply from Authors re: Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series. Eur Urol. In press. DOI:10.1016/j.eururo.2011.12.051
DOI: 10.1016/j.eururo.2012.01.041
We read with interest the editorial comment made by Inman on our recent paper that compared short-term in-hospital outcomes between open nephroureterectomy (ONU) versus laparoscopic nephroureterectom...
|
Nawar Hanna,
Maxine Sun,
Marco Bianchi,
Pierre I. Karakiewicz
|
Editorial
(In Press Corrected Proof)
|
02 February 2012 |
|
Management of Small Renal Masses: Watch, Cut, Freeze, or Fry?
DOI: 10.1016/j.eururo.2012.01.042
The American Cancer Society estimated that >58 000 patients will be diagnosed with a renal malignancy in 2011, resulting in 13 000 deaths , with renal cell carcinoma constituting most of those tumo...
|
Jose A. Karam,
Christopher G. Wood
|
Editorial
(In Press Uncorrected Proof)
|
02 February 2012 |
|
Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire
DOI: 10.1016/j.eururo.2012.01.039
The poor outcome of muscle-invasive bladder cancer (MIBC) is challenging . Neoadjuvant cisplatin-containing combination chemotherapy increases survival by 5–7% and is a grade A recommendation in the c...
|
Maximilian Burger,
Peter Mulders,
Wim Witjes
|
Correspondence
(In Press Uncorrected Proof)
|
02 February 2012 |
|
Reply From the Authors re: Quoc-Dien Trinh, Jesse Sammon, Maxine Sun, et al. Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample. Eur Urol. In press. DOI:10.1016/j.eururo.2011.12.027: Robotic Prostatectomy: Men Versus Machines—The Machines Are Already Here
DOI: 10.1016/j.eururo.2012.01.040
We read with great interest the editorial by Meeks and Eastham commenting on our paper , which showed that robot-assisted radical prostatectomy (RARP) is associated with better perioperative outcomes...
|
Quoc-Dien Trinh,
Maxine Sun,
Jesse Sammon,
Mani Menon,
Pierre I. Karakiewicz
et al.
|
Editorial
(In Press Corrected Proof)
|
02 February 2012 |
|
Laparoendoscopic Single-Site and Conventional Laparoscopic Radical Nephrectomy Result in Equivalent Surgical Trauma: Preliminary Results of a Single-Centre Retrospective Controlled Study
DOI: 10.1016/j.eururo.2012.01.043
Abstract: Background: Laparoendoscopic single-site surgery (LESS) has been developed in an attempt to further reduce the morbidity and scarring associated with surgical intervention, and it has been p...
|
Francesco Greco,
M. Raschid Hoda,
Nasreldin Mohammed,
Christopher Springer,
Kersten Fischer,
Paolo Fornara
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
02 February 2012 |
|
Tension-Free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence: Efficacy and Adverse Effects at 10-Year Follow-Up
DOI: 10.1016/j.eururo.2012.01.038
Abstract: Background: One of the most effective and popular current procedures for the surgical treatment of stress urinary incontinence (SUI) is tension-free midurethral slings. Objective: To evaluat...
|
Maurizio Serati,
Fabio Ghezzi,
Elena Cattoni,
Andrea Braga,
Gabriele Siesto,
Marco Torella,
Antonella Cromi,
Domenico Vitobello,
Stefano Salvatore
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 January 2012 |
|
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index
DOI: 10.1016/j.eururo.2012.01.037
Abstract: Background: There is little consensus on a standard approach to analysing bone scan images. The Bone Scan Index (BSI) is predictive of survival in patients with progressive prostate cancer (...
|
David Ulmert,
Reza Kaboteh,
Josef J. Fox,
Caroline Savage,
Michael J. Evans,
Hans Lilja,
Per-Anders Abrahamsson,
Thomas Björk,
Axel Gerdtsson,
Anders Bjartell,
Peter Gjertsson,
Peter Höglund,
Milan Lomsky,
Mattias Ohlsson,
Jens Richter,
May Sadik,
Michael J. Morris,
Howard I. Scher,
Karl Sjöstrand,
Alice Yu,
Madis Suurküla,
Lars Edenbrandt,
Steven M. Larson
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
Re: Kari A.O. Tikkinen, Anssi Auvinen. Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests? Eur Urol. In press. DOI: 10.1016/j.eururo.2011.12.013: The Origin of the Term Overactive Bladder, Industry, and Patient Care
DOI: 10.1016/j.eururo.2012.01.024
Thank you for allowing us to comment on this interesting editorial that raises a number of important points.
|
Paul Abrams,
Alan Wein
|
Editorial
(In Press Corrected Proof)
|
25 January 2012 |
|
Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer
DOI: 10.1016/j.eururo.2012.01.023
Only 3 yr from the date of its last publication , the US Preventive Services Task Force (USPSTF) has updated its recommendations for prostate cancer (PCa) screening. In the 2008 version, prostate-spec...
|
Maciej Kwiatkowski,
Laurence Klotz,
Jonas Hugosson,
Franz Recker
|
Correspondence
(In Press Corrected Proof)
|
25 January 2012 |
|
Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification
DOI: 10.1016/j.eururo.2012.01.019
Abstract: Background: The clinical course of pT3 upper tract urothelial carcinoma (UTUC) is highly variable. Objectives: The aim of the current study was to validate the clinical and prognostic import...
|
Shahrokh F. Shariat,
Richard Zigeuner,
Michael Rink,
Vitaly Margulis,
Jens Hansen,
Eiji Kikuchi,
Wassim Kassouf,
Jay D. Raman,
Mesut Remzi,
Theresa M. Koppie,
Karim Bensalah,
Charles C. Guo,
Shuji Mikami,
Kanishka Sircar,
Casey K. Ng,
Andrea Haitel,
Wareef Kabbani,
Felix K. Chun,
Christopher G. Wood,
Douglas S. Scherr,
Pierre I. Karakiewicz,
Cord Langner
et al.
|
Full-length article
(In Press Corrected Proof)
|
25 January 2012 |
|
Cancer Control and Functional Outcomes of Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Systematic Review of the Literature
DOI: 10.1016/j.eururo.2012.01.022
Abstract: Context: Prostate cancer (PCa) recurrence following definitive radiation therapy (RT) remains a vexing challenge for the practicing physician. Salvage radical prostatectomy (SRP) has not bee...
|
Daher C. Chade,
James Eastham,
Markus Graefen,
Jim C. Hu,
R. Jeffrey Karnes,
Laurence Klotz,
Francesco Montorsi,
Hendrik van Poppel,
Peter T. Scardino,
Shahrokh F. Shariat
et al.
|
Review article
(In Press Corrected Proof)
|
24 January 2012 |
|
Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients
DOI: 10.1016/j.eururo.2012.01.020
Abstract: Background: We recently identified apolipoprotein A2 (ApoA2) and serum amyloid α (SAA) as independent prognosticators in metastatic renal cell carcinoma (mRCC) patients, thereby improving th...
|
Joost S. Vermaat,
Frank L. Gerritse,
Astrid A. van der Veldt,
Wijnand M. Roessingh,
Tatjana M. Niers,
Sjoukje F. Oosting,
Stefan Sleijfer,
Jeanine M. Roodhart,
Jos H. Beijnen,
Jan H. Schellens,
Jourik A. Gietema,
Epie Boven,
Dick J. Richel,
John B. Haanen,
Emile E. Voest
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
DOI: 10.1016/j.eururo.2012.01.021
Abstract: Background: Novel prognostic factors for patients after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) have recently been described. Objective: We tested the pr...
|
Eugene K. Cha,
Shahrokh F. Shariat,
Matthias Kormaksson,
Giacomo Novara,
Thomas F. Chromecki,
Douglas S. Scherr,
Yair Lotan,
Jay D. Raman,
Wassim Kassouf,
Richard Zigeuner,
Mesut Remzi,
Karim Bensalah,
Alon Weizer,
Eiji Kikuchi,
Christian Bolenz,
Marco Roscigno,
Theresa M. Koppie,
Casey K. Ng,
Hans-Martin Fritsche,
Kazumasa Matsumoto,
Thomas J. Walton,
Behfar Ehdaie,
Stefan Tritschler,
Harun Fajkovic,
Juan I. Martínez-Salamanca,
Armin Pycha,
Cord Langner,
Vincenzo Ficarra,
Jean-Jacques Patard,
Francesco Montorsi,
Christopher G. Wood,
Pierre I. Karakiewicz,
Vitaly Margulis
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
DOI: 10.1016/j.eururo.2012.01.013
Abstract: Background: Tadalafil improved lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH; LUTS/BPH) in clinical studies but has not been evaluated together with an ...
|
Matthias Oelke,
François Giuliano,
Vincenzo Mirone,
Lei Xu,
David Cox,
Lars Viktrup
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
DOI: 10.1016/j.eururo.2012.01.017
Abstract: Background: Preliminary research has suggested the potential prognostic value of circulating tumor cells (CTC) in patients with advanced nonmetastatic urothelial carcinoma of the bladder (UC...
|
Michael Rink,
Felix K. Chun,
Roland Dahlem,
Armin Soave,
Sarah Minner,
Jens Hansen,
Malgorzata Stoupiec,
Cornelia Coith,
Luis A. Kluth,
Sascha A. Ahyai,
Martin G. Friedrich,
Shahrokh F. Shariat,
Margit Fisch,
Klaus Pantel,
Sabine Riethdorf
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non–Muscle-Invasive Bladder Cancer Recurrence
DOI: 10.1016/j.eururo.2012.01.018
Abstract: Background: Narrow band imaging (NBI) is an optical enhancement technology that filters white light into two bandwidths of illumination centered on 415nm (blue) and 540nm (green). NBI cystos...
|
Angelo Naselli,
Carlo Introini,
Luca Timossi,
Bruno Spina,
Vincenzo Fontana,
Riccardo Pezzi,
Francesco Germinale,
Franco Bertolotto,
Paolo Puppo
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Clinical, Molecular, and Genetic Correlates of Lymphatic Spread in Clear Cell Renal Cell Carcinoma
DOI: 10.1016/j.eururo.2012.01.012
Abstract: Background: While it is well known that clear cell renal cell carcinoma (ccRCC) that presents with lymphatic spread is associated with an extremely poor prognosis, its molecular and genetic ...
|
Nils Kroeger,
David B. Seligson,
Tobias Klatte,
Edward N. Rampersaud,
Frédéric D. Birkhäuser,
P. Nagesh Rao,
John T. Leppert,
Nazy Zomorodian,
Fairooz F. Kabbinavar,
Arie S. Belldegrun,
Allan J. Pantuck
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 January 2012 |
|
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers
DOI: 10.1016/j.eururo.2012.01.011
Abstract: Background: DNA methylation markers could serve as useful biomarkers, both as markers for progression and for urine-based diagnostic assays. Objective: Identify bladder cancer (BCa)–specific...
|
Raju Kandimalla,
Angela A.G. van Tilborg,
Lucie C. Kompier,
Dominique J.P.M. Stumpel,
Ronald W. Stam,
Chris H. Bangma,
Ellen C. Zwarthoff
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 January 2012 |
|
Re: Gianluca Giannarini, Thomas M. Kessler, Frédéric D. Birkhäuser, George N. Thalmann, Urs E. Studer. Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit? Eur Urol 2011;60:955–60
DOI: 10.1016/j.eururo.2012.01.014
The literature regarding the long-term efficacy and tolerability of antegrade bacillus Calmette-Guerin (BCG) for non–muscle-invasive upper tract urothelial cancer is scarce. The present study by Giann...
|
Apul Goel,
Swarnendu Mandal,
Sachin B. Patil
|
Correspondence
(In Press Corrected Proof)
|
18 January 2012 |
|
Reply to Apul Goel, Swarnendu Mandal, Sachin B. Patil's Letter to the Editor re: Gianluca Giannarini, Thomas M. Kessler, Frédéric D. Birkhäuser, George N. Thalmann, Urs E. Studer. Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit? Eur Urol 2011;60:955-60
DOI: 10.1016/j.eururo.2012.01.015
We appreciate the interest of Goel et al. in our recent article, published in the Platinum Journal, which reports on our long-term experience with antegrade bacillus Calmette-Guérin (BCG) perfusion of...
|
Gianluca Giannarini,
Urs E. Studer
|
Correspondence
(In Press Corrected Proof)
|
18 January 2012 |
|
How Should We Understand the Term Androgen Deprivation Therapy?
DOI: 10.1016/j.eururo.2012.01.016
Many authors use the term androgen deprivation therapy (ADT) to indicate any treatment that decreases testosterone either to the prostate or in the serum. Is this usage correct?
|
Tomasz Drewa,
Mark S. Soloway
|
Correspondence
(In Press Corrected Proof)
|
18 January 2012 |
|
EAU Guidelines on Laser Technologies
DOI: 10.1016/j.eururo.2012.01.010
Abstract: Context: The European Association of Urology (EAU) Guidelines Office has set up a guideline working panel to analyse the scientific evidence published in the world literature on lasers in ur...
|
Thomas R.W. Herrmann,
Evangelos N. Liatsikos,
Udo Nagele,
Olivier Traxer,
Axel S. Merseburger,
EAU Guidelines Panel on Lasers, Technologies
et al.
|
Practice guideline
(In Press Corrected Proof)
|
18 January 2012 |
|
Robotic Partial Nephrectomy Versus Laparoscopic Cryoablation for the Small Renal Mass
DOI: 10.1016/j.eururo.2012.01.007
Abstract: Background: Open partial nephrectomy (OPN) remains the gold standard for treatment of small renal masses (SRMs). Laparoscopic cryoablation (LCA) has provided encouraging outcomes. Robotic pa...
|
Julien Guillotreau,
Georges-Pascal Haber,
Riccardo Autorino,
Ranko Miocinovic,
Shahab Hillyer,
Adrian Hernandez,
Humberto Laydner,
Rachid Yakoubi,
Wahib Isac,
Jean-Alexandre Long,
Robert J. Stein,
Jihad H. Kaouk
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen
DOI: 10.1016/j.eururo.2012.01.008
Abstract: Background: Population-based screening for prostate cancer (PCa) has used serum prostate-specific antigen (PSA) since the early 1990s. However, the efficacy could be affected by screening in...
|
Grace Hui-Min Wu,
Anssi Auvinen,
Amy Ming-Fang Yen,
Matti Hakama,
Teuvo L. Tammela,
Ulf-Håkan Stenman,
Paula Kujala,
Mirja Ruutu,
Hsiu-Hsi Chen
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Contemporary Management of Ureteral Stones
DOI: 10.1016/j.eururo.2012.01.009
Abstract: Context: Ureteral calculi represent a common condition that urologists encounter in everyday practice. Several treatment options are available for calculi that do not pass spontaneously or a...
|
Markus J. Bader,
Brian Eisner,
Francesco Porpiglia,
Glen M. Preminger,
Hans-Goran Tiselius
et al.
|
Review article
(In Press Corrected Proof)
|
16 January 2012 |
|
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84
DOI: 10.1016/j.eururo.2012.01.005
Recently, van Rhijn et al. presented the validation of a novel substaging system of pT1 bladder cancer (BCa) in European Urology, reporting microinvasive and extensive-invasive T1 BCa as independent p...
|
Maximilian Burger,
Wolfgang Otto,
Arndt Hartmann
|
Correspondence
(In Press Corrected Proof)
|
12 January 2012 |
|
Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84
DOI: 10.1016/j.eururo.2012.01.006
Improvement of care is the ultimate goal in oncology. T1 bladder cancer (BCa) is an entity in which such an improvement is urgently needed because, as urologists, we lack accurate prognostic parameter...
|
Bas W.G. van Rhijn,
Theo H. van der Kwast,
Michael A.S. Jewett,
Alexandre R. Zlotta
|
Correspondence
(In Press Corrected Proof)
|
12 January 2012 |
|
Radical Prostatectomy for Long-Term Functional and Oncologic Outcomes
DOI: 10.1016/j.eururo.2012.01.004
The management of prostate cancer (PCa) is controversial and is under intense public scrutiny. PCa deserves the limelight because it is the most common cancer diagnosed and the second most common caus...
|
Herbert Lepor
|
Editorial
(In Press Corrected Proof)
|
12 January 2012 |
|
Percutaneous Nephrolithotomy in the United Kingdom: Results of a Prospective Data Registry
DOI: 10.1016/j.eururo.2012.01.003
Abstract: Background: Percutaneous nephrolithotomy (PCNL) is commonly used in the management of large upper renal tract stones. It is highly effective but carries a greater risk of significant morbidi...
|
James N. Armitage,
Stuart O. Irving,
Neil A. Burgess,
for the British Association of Urological Surgeons Section of Endourology
|
Full-length article
(In Press Corrected Proof)
|
12 January 2012 |
|
Vesicoureteral Reflux: Current Trends in Diagnosis, Screening, and Treatment
DOI: 10.1016/j.eururo.2012.01.002
Abstract: Context: Vesicoureteral reflux (VUR) is present in approximately 1% of children in North America and Europe and is associated with an increased risk of pyelonephritis and renal scarring. Des...
|
Jonathan C. Routh,
Guy A. Bogaert,
Martin Kaefer,
Gianantonio Manzoni,
John M. Park,
Alan B. Retik,
H. Gil Rushton,
Warren T. Snodgrass,
Duncan T. Wilcox
et al.
|
Review article
(In Press Corrected Proof)
|
12 January 2012 |
|
Predictors of Attendance for Prostate-Specific Antigen Screening Tests and Prostate Biopsy
DOI: 10.1016/j.eururo.2011.12.059
Abstract: Background: Little is known about factors influencing men's decisions to undergo screening and diagnostic tests for prostate cancer (PCa). Objective: Identify predictors of attendance for pr...
|
Kerry N.L. Avery,
Chris Metcalfe,
Kavita Vedhara,
J. Athene Lane,
Michael Davis,
David E. Neal,
Freddie C. Hamdy,
Jenny L. Donovan,
Jane M. Blazeby
et al.
|
Full-length article
(In Press Corrected Proof)
|
11 January 2012 |
|
Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up
DOI: 10.1016/j.eururo.2012.01.001
Abstract: Background: Long-term comparative outcomes for radiofrequency ablation (RFA) versus partial nephrectomy (PN) for the primary treatment of clinical T1a renal cell carcinoma (RCC) have not pre...
|
Ephrem O. Olweny,
Samuel K. Park,
Yung K. Tan,
Sara L. Best,
Clayton Trimmer,
Jeffrey A. Cadeddu
et al.
|
Full-length article
(In Press Corrected Proof)
|
11 January 2012 |
|
Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests?
DOI: 10.1016/j.eururo.2011.12.013
The tendency has always been strong to believe that whatever received a name must be an entity or being, having an independent existence of its own. And if no real entity answering to the name could b...
|
Kari A.O. Tikkinen,
Anssi Auvinen
|
Editorial
(In Press Corrected Proof)
|
06 January 2012 |
|
Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma
DOI: 10.1016/j.eururo.2011.12.055
Accurate appraisal of cause of death (COD) is critically important for determining correct cause-specific survival in cancer patients. Death certificates are used for assessment of COD in case control...
|
Michael Rink,
Harun Fajkovic,
Eugene K. Cha,
Amit Gupta,
Pierre I. Karakiewicz,
Felix K. Chun,
Yair Lotan,
Shahrokh F. Shariat
et al.
|
Correspondence
(In Press Corrected Proof)
|
06 January 2012 |
|
Robotic Prostatectomy: The Rise of the Machines or Judgment Day
DOI: 10.1016/j.eururo.2011.12.053
Utilization of robotic prostatectomy has increased since its introduction in 2000 . Trinh et al provide a national snapshot of the current trends in surgical treatment of prostate cancer (PCa) . Altho...
|
Joshua J. Meeks,
James A. Eastham
|
Editorial
(In Press Corrected Proof)
|
06 January 2012 |
|
Extent of Cancer of Less Than 50% in Any Prostate Needle Biopsy Core: How Many Millimeters Are There?
DOI: 10.1016/j.eururo.2011.12.050
The primary goal of needle biopsy is to diagnose prostatic adenocarcinoma. Once prostate cancer (PCa) is detected, further descriptive information regarding the type of cancer, the amount of tumor, an...
|
Rodolfo Montironi,
Marina Scarpelli,
Roberta Mazzucchelli,
Liang Cheng,
Antonio Lopez-Beltran,
Francesco Montorsi
et al.
|
Editorial
(In Press Corrected Proof)
|
06 January 2012 |
|
Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
DOI: 10.1016/j.eururo.2011.12.056
Abstract: Background: Emerging data suggest botulinum toxin is an effective treatment for detrusor overactivity (DO), but large studies confirming efficacy and safety are lacking. Objective: Study the...
|
Douglas G. Tincello,
Sara Kenyon,
Keith R. Abrams,
Christopher Mayne,
Philip Toozs-Hobson,
David Taylor,
Mark Slack
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial
DOI: 10.1016/j.eururo.2011.12.057
Abstract: Background: Elderly patients with metastatic renal cell carcinoma (mRCC) may require special treatment considerations, particularly when comorbidities are present. An understanding of the ef...
|
Camillo Porta,
Emiliano Calvo,
Miguel A. Climent,
Ulka Vaishampayan,
Susanne Osanto,
Alain Ravaud,
Sergio Bracarda,
Thomas E. Hutson,
Bernard Escudier,
Viktor Grünwald,
Dennis Kim,
Ashok Panneerselvam,
Oezlem Anak,
Robert J. Motzer
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial
DOI: 10.1016/j.eururo.2011.12.058
Abstract: Background: The complications of prostate needle biopsy (PNB) are important when considering the benefits and harms of prostate cancer screening. Studies from the United States and Canada ha...
|
Stacy Loeb,
Suzanne van den Heuvel,
Xiaoye Zhu,
Chris H. Bangma,
Fritz H. Schröder,
Monique J. Roobol
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Reply from Authors re: William D. Steers. Remarks about Remarkable Surgical Outcomes. Eur Urol. In Press. DOI:10.1016/j.eururo.2011.12.035
DOI: 10.1016/j.eururo.2011.12.049
We appreciate the opportunity to respond to Dr. Steers’ commentary concerning our prospective radical prostatectomy (RP) study , which was conceived to see how well open retropubic RP (ORRP) could be ...
|
Robert P. Myers,
R. Jeffrey Karnes
|
Editorial
(In Press Corrected Proof)
|
05 January 2012 |
|
Reply from Authors re: Alexander Kutikov, Marc C. Smaldone, Brian L. Egleston, Robert G. Uzzo. Should Partial Nephrectomy Be Offered to All Patients Whenever Technically Feasible? Eur Urol. In press. DOI:10.1016/j.eururo.2011.12.014
DOI: 10.1016/j.eururo.2011.12.054
We read with great interest the editorial comment by Kutikov and colleagues regarding our recent publication demonstrating a non-cancer-related survival benefit in patients diagnosed with small renal...
|
Maxine Sun,
Quoc-Dien Trinh,
Pierre I. Karakiewicz
|
Editorial
(In Press Corrected Proof)
|
05 January 2012 |
|
Open Versus Laparoscopic Nephroureterectomy: Is There Really a Debate?
DOI: 10.1016/j.eururo.2011.12.051
On March 17, 1987, Phillippe Mouret performed the first laparoscopic cholecystectomy in Lyon, France . Despite the initial absence of any trials demonstrating superiority, within 5 yr of its inception...
|
Brant A. Inman
|
Editorial
(In Press Corrected Proof)
|
05 January 2012 |
|
Personalized Treatment of Prostate Cancer Based on Inherited Variations of Steroid Pathway–Related Genes
DOI: 10.1016/j.eururo.2011.12.052
There is increasing evidence that genetic differences of genes involved in the synthesis and biotransformation of steroid hormones are independent predictors of outcome in prostate cancer (PCa). In th...
|
Tilman Todenhöfer,
Christian Schwentner,
Arnulf Stenzl
|
Editorial
(In Press Corrected Proof)
|
05 January 2012 |
|
Anatomic Grading of Nerve Sparing During Robot-Assisted Radical Prostatectomy
DOI: 10.1016/j.eururo.2011.12.048
Abstract: Background: Because of the lack of intraoperative visual cues, the amount of nerve sparing (NS) intended by the surgeon does not always correspond to what is actually performed during surger...
|
Oscar Schatloff,
Sanket Chauhan,
Ananthakrishnan Sivaraman,
Darian Kameh,
Kenneth J. Palmer,
Vipul R. Patel
et al.
|
Full-length article
(In Press Corrected Proof)
|
05 January 2012 |
|
Reply to Pascal Mouracade's Letter to the Editor re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. Eur Urol. In press. DOI:10.1016/j.eururo.2011.10.043
DOI: 10.1016/j.eururo.2011.12.042
The authors thank Dr. Mouracade for his interest and comments on our paper evaluating trigone-sparing versus trigone-including intradetrusor injections of abobotulinumtoxinA in patients with refractor...
|
Rustom P. Manecksha,
Ivor M. Cullen,
Sarfraz Ahmad,
Graeme McNeill,
Robert Flynn,
Thomas E.D. McDermott,
Ronald Grainger,
John A. Thornhill
et al.
|
Correspondence
(In Press Corrected Proof)
|
30 December 2011 |
|
Re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. Eur Urol. In press. DOI:10.1016/j.eururo.2011.10.043
DOI: 10.1016/j.eururo.2011.12.043
In this paper , Manecksha et al. evaluate the efficacy and safety of trigone-including versus trigone-sparing intradetrusor injections of abobotulinumtoxinA in patients with idiopathic detrusor overac...
|
Pascal Mouracade
|
Correspondence
(In Press Corrected Proof)
|
30 December 2011 |
|
Reply from Authors re: Giuseppe Simone, Michele Gallucci. Multimodality Treatment Versus Radical Cystectomy: Bladder Sparing at Cost of Life? Eur Urol. In press. DOI:10.1016/j.eururo.2011.11.051: Bladder-Sparing Therapy: The Urologist Doth Protest Too Much, Methinks
DOI: 10.1016/j.eururo.2011.12.045
We agree with the authors of the editorial that the primary goal of any treatment for muscle-invasive bladder cancer should be cure and optimized survival, and secondary goals include preventing fail...
|
Jason A. Efstathiou,
William U. Shipley,
Anthony L. Zietman
|
Editorial
(In Press Corrected Proof)
|
30 December 2011 |
|
Nodal Staging in Prostate Cancer: Still an Unresolved Issue
DOI: 10.1016/j.eururo.2011.12.044
Until now, pelvic lymph node dissection (PLND) has proven to be the most accurate and reliable nodal staging procedure in prostate cancer (PCa), as currently available imaging techniques report low se...
|
Steven Joniau,
Laura Van den Bergh,
Charlotte Peeters,
Karin Haustermans,
Martin Spahn
et al.
|
Editorial
(In Press Corrected Proof)
|
29 December 2011 |
|
Remarks about Remarkable Surgical Outcomes
DOI: 10.1016/j.eururo.2011.12.035
This prospective series from the Mayo Clinic attempts to update and refine the technique for open radical prostatectomy (ORP) for the treatment of localized prostate cancer . The authors propose that ...
|
William D. Steers
|
Editorial
(In Press Corrected Proof)
|
26 December 2011 |
|
Reply from Authors re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol. In press. DOI: 10.1016/j.eururo.2011.11.050
DOI: 10.1016/j.eururo.2011.12.022
We thank Loeb for the positive and insightful editorial regarding our study on prostate-specific antigen (PSA) for long-term prediction of prostate cancer (PCa) incidence and mortality . We fully agr...
|
David D. Ørsted,
Børge G. Nordestgaard,
Gorm B. Jensen,
Peter Schnohr,
Stig E. Bojesen
et al.
|
Editorial
(In Press Corrected Proof)
|
26 December 2011 |
|
Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series
DOI: 10.1016/j.eururo.2011.12.026
Abstract: Background: Nephroureterectomy (NU) represents the primary management for patients with nonmetastatic upper tract urothelial carcinoma (UTUC). Either an open NU (ONU) or a laparoscopic NU (L...
|
Nawar Hanna,
Maxine Sun,
Quoc-Dien Trinh,
Jens Hansen,
Marco Bianchi,
Francesco Montorsi,
Shahrokh F. Shariat,
Markus Graefen,
Paul Perrotte,
Pierre I. Karakiewicz
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample
DOI: 10.1016/j.eururo.2011.12.027
Abstract: Background: Prior to the introduction and dissemination of robot-assisted radical prostatectomy (RARP), population-based studies comparing open radical prostatectomy (ORP) and minimally inva...
|
Quoc-Dien Trinh,
Jesse Sammon,
Maxine Sun,
Praful Ravi,
Khurshid R. Ghani,
Marco Bianchi,
Wooju Jeong,
Shahrokh F. Shariat,
Jens Hansen,
Jan Schmitges,
Claudio Jeldres,
Craig G. Rogers,
James O. Peabody,
Francesco Montorsi,
Mani Menon,
Pierre I. Karakiewicz
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
DOI: 10.1016/j.eururo.2011.12.028
Abstract: Context: Improved understanding of mechanisms underlying metastatic castration-resistant prostate cancer (mCRPC) progression has led to the recognition of multiple molecular targets and adva...
|
Neeraj Agarwal,
Guru Sonpavde,
Cora N. Sternberg
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Emphasis on Cancer Control and Complications. Eur Urol 2011;60:767–75.
DOI: 10.1016/j.eururo.2011.12.015
We read with great interest the paper by Challacombe et al. concerning minimally invasive radical cystectomy (MIRC)—an impressive review of the literature on this challenging subject . Radical cystect...
|
Alchiede Simonato,
Marco Ennas
|
Correspondence
(In Press Corrected Proof)
|
22 December 2011 |
|
Reply to Alchiede Simonato and Marco Ennas’ Letter to the Editor re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Emphasis on Cancer Control and Complications. Eur Urol 2011;60:767–75
DOI: 10.1016/j.eururo.2011.12.016
On behalf of the authors, we would like to thank Simonato for views on our recent collaborative review . The authors of this collaborative review represent opinion-leading surgeons at both extremes of...
|
Ben Challacombe,
Prokar Dasgupta
|
Correspondence
(In Press Corrected Proof)
|
22 December 2011 |
|
Reply from Authors re: Christopher R. Chapple. Which Preparation of Botulinum Toxin A Should Be Used, Where Should It Be Injected, and How Should Its Efficacy Be Assessed? Eur Urol. In press. DOI:10.1016/j.eururo.2011.12.005
DOI: 10.1016/j.eururo.2011.12.017
The insightful editorial by Chapple regarding our paper on where to inject botulinum toxin A (BoNTA) is welcomed. BoNTA is now widely utilised in idiopathic detrusor overactivity; however, there are...
|
Rustom P. Manecksha,
Ivor M. Cullen,
Sarfraz Ahmad,
Graeme McNeill,
Robert Flynn,
TED McDermott,
Ronald Grainger,
John A. Thornhill
et al.
|
Editorial
(In Press Corrected Proof)
|
22 December 2011 |